9.20
Viemed Healthcare Inc Azioni (VMD) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
5.93%
76.18
|
71.91 | 63.06 | 59.13 | 60.70 |
| Cost Of Revenue |
4.94%
32.08
|
30.57 | 26.32 | 25.85 | 24.56 |
| Gross Profit |
6.67%
44.10
|
41.34 | 36.73 | 33.28 | 36.14 |
|
|
0.08%
35.73
|
35.70 | 31.64 | 29.44 | 29.69 |
| Benefits Costs and Expenses |
2.09%
68.17
|
66.78 | 58.09 | 55.47 | 54.39 |
| Costs And Expenses |
2.09%
68.17
|
66.78 | 58.09 | 55.47 | 54.39 |
| Depreciation and Amortization |
2.52%
0.387
|
0.397 | 0.353 | 0.348 | 0.343 |
| Operating Income/Loss |
48.37%
8.371
|
5.642 | 5.095 | 3.841 | 6.452 |
| Income/Loss From Equity Method Investments |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations Before Tax |
55.93%
8.007
|
5.135 | 4.963 | 3.662 | 6.305 |
| Income Tax Expense/Benefit, Deferred |
91.90%
0.38
|
4.69 | - | - | -0.333 |
| Income Tax Expense/Benefit |
42.74%
2.191
|
1.535 | 1.713 | 0.952 | 1.881 |
| Income/Loss From Continuing Operations After Tax |
61.56%
5.816
|
3.60 | 3.25 | 2.71 | 4.424 |
|
|
61.56%
5.816
|
3.60 | 3.25 | 2.71 | 4.424 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
103.45%
0.177
|
0.087 | 0.093 | 0.085 | 0.108 |
| Basic Average Shares |
100.76%
-0.2954
|
38.64 | 39.52 | 39.43 | -0.049 |
| Diluted Average Shares |
100.65%
-0.2624
|
40.50 | 41.08 | 41.63 | 0.1031 |
| Basic Earnings Per Share |
55.56%
0.14
|
0.09 | 0.08 | 0.07 | 0.11 |
| Diluted Earnings Per Share |
55.56%
0.14
|
0.09 | 0.08 | 0.06 | 0.11 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):